Halozyme Therapeutics (HALO) Finished Goods (2011 - 2026)
Halozyme Therapeutics (HALO) posted Finished Goods of $91.18 million for Q2 2026, down 44.7% from $164.87 million a year earlier and down 19.6% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Finished Goods (2011 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Finished Goods came in at $144.45 million, up 1.1% from FY2024.
- Annual Finished Goods has increased for ten consecutive years, with a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Finished Goods was $142.94 million in FY2024 (+104.4%), $69.93 million in FY2023 (+52.1%), $45.97 million in FY2022 (+78.3%) and $25.79 million in FY2021 (+21.7%).
- The Q2 2026 figure stands as the lowest quarterly Finished Goods since Q4 2023.
- On a year-over-year basis, Finished Goods increased in six of the last eight quarters, with growth averaging 31.9%.
- The strongest year-over-year quarter for Finished Goods in the past five years was Q3 2024, with growth of 122.8%; the weakest was Q2 2026, with a decline of 44.7%.
- According to Business Quant data, Finished Goods for the three prior quarters was $113.37 million (Q1 2026), $144.45 million (Q4 2025) and $161.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.18 Mn |
| Mar 31, 2026 | 113.37 Mn |
| Dec 31, 2025 | 144.45 Mn |
| Sep 30, 2025 | 161.59 Mn |
| Jun 30, 2025 | 164.87 Mn |
| Mar 31, 2025 | 143.24 Mn |
| Dec 31, 2024 | 142.94 Mn |
| Sep 30, 2024 | 143.52 Mn |
| Jun 30, 2024 | 126.64 Mn |
| Mar 31, 2024 | 95.82 Mn |
| Dec 31, 2023 | 69.93 Mn |
| Sep 30, 2023 | 64.42 Mn |
| Jun 30, 2023 | 57.86 Mn |
| Mar 31, 2023 | 57.67 Mn |
| Dec 31, 2022 | 45.97 Mn |
| Sep 30, 2022 | 35.07 Mn |
| Jun 30, 2022 | 43.26 Mn |
| Mar 31, 2022 | 31.16 Mn |
| Dec 31, 2021 | 25.79 Mn |
| Sep 30, 2021 | 26.15 Mn |
API Access
Halozyme Therapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();